HPV vaccination prevents most cases of cervical cancer
Vaccination against the human papillomavirus (HPV) offers highly effective protection against cervical cancer. These findings are from the first group of women who could get the HPV vaccination and have a smear test.
National Immunisation Programme: more cases of illness in 2023
In 2023, more people in the Netherlands contracted a disease which is vaccinated against in the context of the National Immunisation Programme (RVP) than in 2022. This is because coronavirus measures, such as physical distancing, were still in effect for part of 2022.
Data from National Immunisation Programme available through MijnRIVM and in personal digital health environments
From 20 November on, data from National Immunisation Programme will be available through the client portal provided by the National Institute for Public Health and the Environment (RIVM): Mijn.RIVM.nl . The data can also be accessed through five personal digital health environments qualified for this purpose.
Changes in childhood vaccination schedule for 2025
Starting in 2025, the vaccination schedule used in the National Immunisation Programme for children will be updated. The changes apply to four scheduled vaccination times. This offers children even better protection against infectious diseases, such as measles and whooping cough.
Vaccination coverage of babies and toddlers remained about the same, but decreased among older children
The percentage of babies and toddlers that were vaccinated in the framework of the National Immunisation Programme remained about the same compared to last year. In children aged 9 years and older, vaccination coverage continued to decrease for most of the national childhood immunisations.
iStock
Start of rotavirus vaccinations
This week saw the start of babies being vaccinated against the rotavirus. This vaccination is included in the Dutch National Immunisation Programme as of this year. All parents of babies born on or after 1 January 2024 will receive an invitation for this.
